EUVIMEDEUVIMED entdecken
Crossref

Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia

Ying-Jung Huang, Shih-Hsiang Chen, Hsi-Che Liu, Tang-Her Jaing, Ting-Chi Yeh, Ming-Chung Kuo, Tung-Liang Lin, Chiu-Chen Chen, Shih-Chung Wang, Te-Kau Chang, Chih-Cheng Hsiao, Der-Cherng Liang und 1 weitere

Pathology · 2024

DOI: 10.1016/j.pathol.2024.02.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology, 2024. Verfasst von Ying-Jung Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Neoplasm, Residual, High-Throughput Nucleotide Sequencing, Oncogene Proteins, Fusion, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Mackay Memorial Hospital, Chang Gung Memorial Hospital, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm, ResidualHigh-Throughput Nucleotide SequencingOncogene Proteins, FusionPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansFemaleMaleAdolescentAdultChildMiddle AgedYoung AdultChild, PreschoolCore Binding Factor Alpha 2 SubunitFusion Proteins, bcr-abl

Stichwörter der Autor:innen

BCR::ABL1ETV6::RUNX1NGSRT-qPCRTCF3::PBX1measurable residual disease

Substanzen

Oncogene Proteins, FusionCore Binding Factor Alpha 2 SubunitFusion Proteins, bcr-abl

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Hematology-Oncology, Chang Gung Children's Hospital at Linkou, Taoyuan, Taiwan.
  • Department of Hematology-Oncology, MacKay Children's Hospital and Mackay Medical College, Taipei, Taiwan.
  • Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Division of Pediatric Hematology-Oncology, Changhua Christian Children's Hospital, Changhua, Taiwan.
  • Division of Pediatric Hematology and Oncology, China Medical University Children's Hospital, Taichung, Taiwan.

Förderung

  • Mackay Memorial Hospital
  • Chang Gung Memorial Hospital
  • Ministry of Health and Welfare

Zitieren

APA

Huang, Y. J., Chen, S. H., Liu, H. C., Jaing, T. H., Yeh, T. C., Kuo, M. C., Lin, T. L., Chen, C. C., Wang, S. C., Chang, T. K., Hsiao, C. C., Liang, D. C., & Shih, L. Y. (2024). Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia. Pathology. https://doi.org/10.1016/j.pathol.2024.02.008

Vancouver

Huang YJ, Chen SH, Liu HC, Jaing TH, Yeh TC, Kuo MC, et al. Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia. Pathology. 2024. doi:10.1016/j.pathol.2024.02.008

BibTeX
@article{Huang2024,
  author = {Huang, Ying-Jung and Chen, Shih-Hsiang and Liu, Hsi-Che and Jaing, Tang-Her and Yeh, Ting-Chi and Kuo, Ming-Chung and Lin, Tung-Liang and Chen, Chiu-Chen and Wang, Shih-Chung and Chang, Te-Kau and Hsiao, Chih-Cheng and Liang, Der-Cherng and Shih, Lee-Yung},
  title = {Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia},
  journal = {Pathology},
  year = {2024},
  doi = {10.1016/j.pathol.2024.02.008}
}
Kostenlos starten →